Compared to the normal mice, the expression of the phosphorylation status of mTOR (Ser2448) significantly increased (approximately 10%–20%) in CDDP-CKD mice in both liver and kidney, while TBN dose-dependently reversed the increase in p-mTOR in the kidney (Figures 6A–D). The gene discussed is MTOR; the disease is chronic kidney disease.